Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia.
Abroad (travel likely)Recruiting
Conditions
Spondylitis, Ankylosing · Mobile Phone Use
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital of Wuerzburg, Würzburg, Bavaria, Germany
Marc Schmalzing, MD (Sub-investigator)Hannah Labinsky, MD (Sub-investigator)Praxisgemeinschaft Rheumatologie Nephrologie Erlangen, Erlangen, Germany
University Hospital of Erlangen, Erlangen, Germany
MVZ Rheumatologie, Hamburg, Germany
Rheumatologische Gemeinschaftspraxis Hattingen, Hattingen, Germany
University Hospital of Marburg, Marburg, Germany
Contact: Study coordinator (Johannes Knitza, MD) · johannes.knitza@staff.uni-marburg.de · 0049 6421 58-62651Klinikum Nürnberg, Nuremberg, Germany
Contact: Study coordinator (Axel Hueber, Prof) · rheumatologie@klinikum-nuernberg.de · 00499113983051Vanessa Bartsch, MD (Sub-investigator)